Fetal and Neonatal Monitoring Devices Market to Reach USD 8.7 Billion by 2036, Germany - CAGR 8.4%, Brazil - CAGR 7.7%, United Kingdom - CAGR 6.2%

Growing demand for continuous maternal and newborn surveillance, portable monitoring equipment and connected clinical workflows is reshaping purchasing priorities, according to Fact.MR.

NEWARK, Del., October 13, 2026. The global fetal and neonatal monitoring devices market is projected to grow from USD 4.3 billion in 2026 to USD 8.7 billion by 2036, registering a compound annual growth rate (CAGR) of 7.2%, according to Fact.MR. The market is expected to generate an incremental opportunity of USD 4.4 billion over the forecast period, as hospitals and other healthcare facilities invest in obstetric monitoring, neonatal intensive care and connected medical equipment.

The market reached USD 4.01 billion in 2025, according to Fact.MR's analysis. Its latest assessment identifies the shift from intermittent checks to continuous maternal and fetal surveillance as a major growth driver. Investment in neonatal intensive care capacity, wider use of portable monitoring systems and demand for integrated patient data are also supporting procurement.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=16706

Continuous surveillance changes purchasing priorities

Healthcare providers are increasingly evaluating monitoring equipment as part of a connected clinical workflow rather than as isolated devices. Fetal monitors, ultrasound systems, fetal dopplers and neonatal monitors serve different functions across pregnancy, labor and newborn care. Buyers are therefore weighing portability, data connectivity, alarm performance, service support and compatibility with existing hospital systems.

Fact.MR identifies high-risk pregnancy monitoring and investment in neonatal intensive care capacity as important sources of demand. Compact ultrasound units and handheld dopplers can also support fetal assessment in clinics and smaller facilities that may not have the space or budget for fixed installations.

However, adoption is not uniform. High equipment costs can constrain purchasing at smaller facilities, while false alarms, differences in interpretation, data security requirements and interoperability challenges can complicate implementation.

Where growth is fastest

Fact.MR's country forecasts show Germany leading the five profiled markets, followed by Brazil and the United States. The United Kingdom provides another European growth market, while Japan's more mature healthcare system is expected to rely comparatively more on equipment upgrades.

Germany - 8.4% CAGR: A well-funded hospital system, regular equipment replacement cycles and demand for connected, higher-specification monitoring systems support growth.
Brazil - 7.7% CAGR: Investment in obstetric and neonatal care capacity across public and private facilities is supporting equipment demand.
United States - 6.9% CAGR: Established hospital monitoring infrastructure and interest in portable, networked and remote-capable devices support replacement and upgrade demand.
United Kingdom - 6.2% CAGR: Maternity service priorities, equipment replacement and digital integration are shaping purchasing activity.
Japan - 5.5% CAGR: A mature obstetric and neonatal care system means technology upgrades are expected to account for a larger share of demand than new capacity.
These forecasts suggest that suppliers will need to balance opportunities in hospital equipment upgrades with the practical requirements of expanding care access in emerging markets.

What leads the market

Three segments account for the leading positions in Fact.MR's 2026 breakdown.

Product type - Ultrasound devices: 38.5% share. Their use in fetal assessment and imaging-led clinical decisions supports their position as the largest product category.
Portability - Portable devices: 55.8% share. Mobility across wards, clinics and bedside settings supports demand for equipment that can be deployed without extensive fixed installations.
End user - Hospitals: 57.3% share. Hospitals manage deliveries, high-risk pregnancies and neonatal admissions, making them the largest end-user category.
The figures point to two linked purchasing priorities: equipment that can move between care settings and systems that can integrate with broader hospital monitoring workflows. For manufacturers, the opportunity extends beyond device specifications to connectivity, training and ongoing service support.

The hurdle: Cost and implementation complexity

Capital expenditure remains a significant constraint, particularly for smaller facilities with limited procurement budgets. Fact.MR also identifies false alarms and variability in clinical interpretation as factors that can limit confidence in monitoring systems.

Data security, interoperability and regulatory compliance add further implementation requirements. These constraints can influence the total cost of ownership, the time required to integrate new equipment and the training needed before clinical teams can use systems effectively.

For suppliers, demonstrating compatibility with existing infrastructure and providing appropriate training and technical support may be as important to purchasing decisions as the device itself.

Industry investment and competitive developments

Fact.MR's report describes competition among medical technology providers with established product portfolios in ultrasound, fetal monitoring, neonatal monitoring and patient surveillance. The report identifies the following companies as key providers:

GE HealthCare
Philips Healthcare
Medtronic
Drägerwerk AG
Natus Medical
Masimo
Fujifilm SonoSite
ICU Medical
Edwards Lifesciences

The report discusses existing product portfolios, including GE HealthCare's Voluson ultrasound systems and Corometrics fetal monitors, Philips Healthcare's Avalon fetal monitors and IntelliVue patient monitoring, Medtronic's Nellcor pulse oximetry and Microstream capnography, and Drägerwerk AG's neonatal incubators, warmers and monitoring solutions. Fujifilm SonoSite is identified in connection with portable point-of-care ultrasound.

These are descriptions of existing portfolios, not announcements of new partnerships or product launches. The report page does not provide dated company developments that can be independently presented as recent announcements.

Analyst perspective

Shambhu Nath Jha, Principal Consultant at Fact.MR, states:

"Fetal and neonatal monitoring is now purchased as a continuous-surveillance capability rather than a standalone device. Providers will favor portable, interoperable systems that integrate ultrasound, fetal and neonatal data into unified workflows. Manufacturers pairing clinically validated platforms with analytics, training and service support will gain the most from hospitals and expanding care networks."

What this means for healthcare procurement teams and device manufacturers

Evaluate total ownership costs before expanding monitoring capacity. Compare purchase costs with installation, staff training, maintenance and integration requirements. Smaller facilities should assess whether portable systems can meet their needs without requiring extensive fixed infrastructure.
Make interoperability a procurement requirement. Assess how proposed devices exchange information with existing hospital systems and central monitoring stations. Buyers should also examine alarm configuration, usability and the training needed to support consistent interpretation.
Align product investment with the strongest demand signals. Portable devices already account for 55.8% of the market, while ultrasound devices lead product types at 38.5%. Manufacturers can use these segment positions to inform product planning while evaluating opportunities in connected monitoring, wireless systems and outpatient maternity care.

Unlock 360° insights for strategic decision making and investment planning: https://www.factmr.com/report/fetal-and-neonatal-monitoring-devices-market

Report coverage

Fact.MR's Fetal and Neonatal Monitoring Devices Market report examines market size and forecasts from 2026 to 2036, product type, portability, end users, country-level growth and the competitive environment.

Explore More Related Studies Published by Fact.MR Research

Powder-Filled Hard Gelatin Capsules Market- https://www.newstrail.com/powder-filled-hard-gelatin-capsules-market-set-to-hit-usd-10-1-billion-by-2036-usa-cagr-6-1/

No Sting Barrier Market- https://www.newstrail.com/no-sting-barrier-market-size-to-surge-to-usd-878-7-million-by-2036-led-by-germany-at-8-3-cagr/

Brain Monitoring Devices Market- https://www.newstrail.com/brain-monitoring-devices-market-to-reach-usd-13-3-billion-by-2036-germany-cagr-7-2-brazil-cagr-6-5/

General Surgical Devices Market- https://www.newstrail.com/general-surgical-devices-market-to-reach-usd-39-8-billion-by-2036-ireland-cagr-7-9/

- Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | sales@factmr.com

About Fact.MR

Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.

This release was published on openPR.